N-acetylcysteine and ambroxol inhibit endotoxin-induced phagocyte accumulation in rat lungs
- PMID: 10587478
- DOI: 10.1006/pupt.1999.0219
N-acetylcysteine and ambroxol inhibit endotoxin-induced phagocyte accumulation in rat lungs
Abstract
We have investigated whether pretreatment with N-acetylcysteine (NAC) and/or ambroxol (Amb), drugs known as reactive oxygen species (ROS) scavengers, would minimize lipopolysaccharide (LPS)-induced leucocyte accumulation in rat lung microvasculature and protect lungs from damage and the effect of these drugs on chemotactic peptide (fMLP)-induced chemiluminescence of human polymorphonuclear leukocytes (PMNs). Animals were injected ip with NAC (27.6 mg/kg, n=8), ambroxol (70 mg/kg, n=8), combination NAC+ambroxol (n=8), or 1 ml buffer alone (n=8), once a day for 3 consecutive days. Then animals were injected with LPS (17 mg/kg), and killed 3 h later. In each of another four groups eight rats were used as a control, and received the same drug treatment but LPS was replaced with 0.9% NaCl. PMNs and macrophages (Ms) were counted in histologic slides of lung tissue. Using computer image analysis we measured the area of alveolar profiles. Luminol-enhanced chemiluminescence was measured in PMNs suspensions obtained from healthy volunteers. Chemiluminescence intensity was measured in resting and fMLP-stimulated cells, and compared between cells incubated with Amb, NAC or distilled water. We observed significant differences in the number of PMNs and Ms, alveolar profile area between control and LPS-treated animals (P<0.01). PMNs and Ms were numerous in lungs of LPS-administered animals (PMNs: Median (M)=137.5 per 6 high power fields range (r)=54.0; Ms: M=123.0 r=11.0), less numerous in ambroxol-treated group (PMNs: M=101.5 r=32.0 and Ms:53.5 r=36.0), not abundant in NAC (PMNs:M=56.0 r=28.0 and Ms:M=20.5 r=13.0) and in NAC+ambroxol treated rats (PMNs:M=53.5 r=21.0 and Ms:M=29.0 r=9.0), and rare in LPS+drugs-untreated control group (PMNs:M=40.5 r=19.0 and Ms:M=18.5 r=15.0). Chemiluminescence assay revealed that 100 micro;M ambroxol stimulated fMLP-induced PMNs chemiluminescence and NAC of the same concentration had no significant effect.
Conclusion: In our experiment we showed that pretreatment with NAC and ambroxol may inhibit phagocyte influx to rat lung and may protect it from damage. We also revealed that NAC at dose 27.6 mg/kg has stronger protective properties than ambroxol at dose 70 mg/kg and this may result from enhancing effect of ambroxol on fMLP-provoked PMNs chemiluminescence.
Copyright 1999 Academic Press.
Similar articles
-
N-acetylcysteine effect on the luminol-dependent chemiluminescence pattern of reactive oxygen species generation by human polymorphonuclear leukocytes.Pulm Pharmacol Ther. 2002;15(4):385-92. doi: 10.1006/pupt.2002.0369. Pulm Pharmacol Ther. 2002. PMID: 12220944
-
Depressant effects of ambroxol on lipopolysaccharide- or fMLP-stimulated free radical production and granule enzyme release by alveolar macrophages.Pulm Pharmacol Ther. 1999;12(5):275-84. doi: 10.1006/pupt.1999.0214. Pulm Pharmacol Ther. 1999. PMID: 10545283
-
Effects of N-acetylcysteine and ambroxol on the production of IL-12 and IL-10 in human alveolar macrophages.Respiration. 2000;67(6):662-71. doi: 10.1159/000056297. Respiration. 2000. PMID: 11124650
-
Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.Respir Med. 1998 Apr;92(4):609-23. doi: 10.1016/s0954-6111(98)90506-6. Respir Med. 1998. PMID: 9659525 Review.
-
Beyond the lungs: Exploring diverse applications of bromhexine and ambroxol.Life Sci. 2024 Sep 15;353:122909. doi: 10.1016/j.lfs.2024.122909. Epub 2024 Jul 11. Life Sci. 2024. PMID: 38997062 Review.
Cited by
-
Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide.Intensive Care Med. 2004 Jan;30(1):133-40. doi: 10.1007/s00134-003-2001-y. Epub 2003 Sep 20. Intensive Care Med. 2004. PMID: 14504727 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources